These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21255742)

  • 21. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal Order of Alzheimer's Disease-Related Cognitive Marker Changes in BLSA and WRAP Longitudinal Studies.
    Bilgel M; Koscik RL; An Y; Prince JL; Resnick SM; Johnson SC; Jedynak BM
    J Alzheimers Dis; 2017; 59(4):1335-1347. PubMed ID: 28731452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical cognitive trajectories differ for Alzheimer's disease and vascular dementia.
    Laukka EJ; Macdonald SW; Fratiglioni L; Bäckman L
    J Int Neuropsychol Soc; 2012 Mar; 18(2):191-9. PubMed ID: 22264384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of motor impairement in normal aging, mild cognitive decline, and early Alzheimer's disease.
    Kluger A; Gianutsos JG; Golomb J; Ferris SH; George AE; Franssen E; Reisberg B
    J Gerontol B Psychol Sci Soc Sci; 1997 Jan; 52B(1):P28-39. PubMed ID: 9008673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.
    Grundman M; Petersen RC; Ferris SH; Thomas RG; Aisen PS; Bennett DA; Foster NL; Jack CR; Galasko DR; Doody R; Kaye J; Sano M; Mohs R; Gauthier S; Kim HT; Jin S; Schultz AN; Schafer K; Mulnard R; van Dyck CH; Mintzer J; Zamrini EY; Cahn-Weiner D; Thal LJ;
    Arch Neurol; 2004 Jan; 61(1):59-66. PubMed ID: 14732621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
    Visser PJ; Verhey F; Knol DL; Scheltens P; Wahlund LO; Freund-Levi Y; Tsolaki M; Minthon L; Wallin AK; Hampel H; Bürger K; Pirttila T; Soininen H; Rikkert MO; Verbeek MM; Spiru L; Blennow K
    Lancet Neurol; 2009 Jul; 8(7):619-27. PubMed ID: 19523877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinction between preclinical Alzheimer's disease and depression.
    Visser PJ; Verhey FR; Ponds RW; Kester A; Jolles J
    J Am Geriatr Soc; 2000 May; 48(5):479-84. PubMed ID: 10811539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neuropathology of older persons with and without dementia from community versus clinic cohorts.
    Schneider JA; Aggarwal NT; Barnes L; Boyle P; Bennett DA
    J Alzheimers Dis; 2009; 18(3):691-701. PubMed ID: 19749406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical Alzheimer's disease: diagnosis and prediction of progression.
    Chong MS; Sahadevan S
    Lancet Neurol; 2005 Sep; 4(9):576-9. PubMed ID: 16109364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
    Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mild cognitive impairment: clinical characterization and outcome.
    Petersen RC; Smith GE; Waring SC; Ivnik RJ; Tangalos EG; Kokmen E
    Arch Neurol; 1999 Mar; 56(3):303-8. PubMed ID: 10190820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a purpose in life on risk of incident Alzheimer disease and mild cognitive impairment in community-dwelling older persons.
    Boyle PA; Buchman AS; Barnes LL; Bennett DA
    Arch Gen Psychiatry; 2010 Mar; 67(3):304-10. PubMed ID: 20194831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1998 Sep; 10(3):271-302. PubMed ID: 9785148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National estimates of the prevalence of Alzheimer's disease in the United States.
    Brookmeyer R; Evans DA; Hebert L; Langa KM; Heeringa SG; Plassman BL; Kukull WA
    Alzheimers Dement; 2011 Jan; 7(1):61-73. PubMed ID: 21255744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The neuropathology of probable Alzheimer disease and mild cognitive impairment.
    Schneider JA; Arvanitakis Z; Leurgans SE; Bennett DA
    Ann Neurol; 2009 Aug; 66(2):200-8. PubMed ID: 19743450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
    Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
    J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States.
    Brookmeyer R; Abdalla N; Kawas CH; Corrada MM
    Alzheimers Dement; 2018 Feb; 14(2):121-129. PubMed ID: 29233480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and natural course of aging-associated cognitive decline in a population-based sample of young-old subjects.
    Schönknecht P; Pantel J; Kruse A; Schröder J
    Am J Psychiatry; 2005 Nov; 162(11):2071-7. PubMed ID: 16263846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease.
    Arnáiz E; Almkvist O
    Acta Neurol Scand Suppl; 2003; 179():34-41. PubMed ID: 12603249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.